Skip to main content

Articles

Page 117 of 154

  1. Authors: Xenofon Baraliakos, Joachim Listing, Jan Brandt, Angela Zink, Rieke Alten, Gerd Burmester, Erika Gromnica-Ihle, Herbert Kellner, Matthias Schneider, Helmut Sörensen, Hennig Zeidler, Martin Rudwaleit, Joachim Sieper and Juergen Braun
    Citation: Arthritis Research & Therapy 2005 7:113

    The original article was published in Arthritis Research & Therapy 2005 7:R439

  2. Heme oxygenase-1 (HO-1), an inducible heme-degrading enzyme, is expressed by macrophages and endothelial cells in response to various stresses. Because ferritin synthesis is stimulated by Fe2+, which is a product...

    Authors: Yohei Kirino, Mitsuhiro Takeno, Mika Iwasaki, Atsuhisa Ueda, Shigeru Ohno, Akira Shirai, Heiwa Kanamori, Katsuaki Tanaka and Yoshiaki Ishigatsubo
    Citation: Arthritis Research & Therapy 2005 7:R616
  3. T cells have an important role during the development of autoimmune diseases. In adjuvant arthritis, a model for rheumatoid arthritis, we found that the percentage of CD4+ T cells expressing the activation marker...

    Authors: Elmieke PJ Boot, Gerben A Koning, Gert Storm, Josée PA Wagenaar-Hilbers, Willem van Eden, Linda A Everse and Marca HM Wauben
    Citation: Arthritis Research & Therapy 2005 7:R604
  4. The prognostic value of two antibodies targeting citrullinated antigens, anti-Sa and anti-cyclic citrullinated peptide (CCP), present at inclusion, was evaluated prospectively in a cohort of 165 consecutive pa...

    Authors: Gilles Boire, Pierre Cossette, Artur J de Brum-Fernandes, Patrick Liang, Théophile Niyonsenga, Zhijie J Zhou, Nathalie Carrier, Claude Daniel and Henri-A Ménard
    Citation: Arthritis Research & Therapy 2005 7:R592
  5. Abatacept (CTLA4–Ig) is a novel fusion protein designed to modulate the T cell co-stimulatory signal mediated through the CD28–CD80/86 pathway. Clinical trials have provided preliminary evidence of the efficac...

    Authors: Eric M Ruderman and Richard M Pope
    Citation: Arthritis Research & Therapy 2005 7(Suppl 2):S21

    This article is part of a Supplement: Volume 7 Supplement 2

  6. Rheumatoid arthritis (RA) is a common destructive inflammatory disease that affects 0.5–1% of the population in many countries. Even though several new treatments have been introduced for patients with RA, a c...

    Authors: Vivianne Malmström, Christina Trollmo and Lars Klareskog
    Citation: Arthritis Research & Therapy 2005 7(Suppl 2):S15

    This article is part of a Supplement: Volume 7 Supplement 2

  7. T cells, in particular CD4+ T cells, have been implicated in mediating many aspects of autoimmune inflammation. However, current evidence suggests that the role played by CD4+ T cells in the development of rheuma...

    Authors: Alla Skapenko, Jan Leipe, Peter E Lipsky and Hendrik Schulze-Koops
    Citation: Arthritis Research & Therapy 2005 7(Suppl 2):S4

    This article is part of a Supplement: Volume 7 Supplement 2

  8. Apart from the deletion of autoreactive T cells in the thymus, various methods exist in the peripheral immune system to control specific human immune responses to self-antigens. One of these mechanisms involve...

    Authors: Jan Leipe, Alla Skapenko, Peter E Lipsky and Hendrik Schulze-Koops
    Citation: Arthritis Research & Therapy 2005 7:93
  9. The objective of the present study was to investigate the effect of leptin, alone or in combination with IL-1, on nitric oxide synthase (NOS) type II activity in vitro in human primary chondrocytes, in the mouse ...

    Authors: Miguel Otero, Rocío Lago, Francisca Lago, Juan Jesús Gomez Reino and Oreste Gualillo
    Citation: Arthritis Research & Therapy 2005 7:R581
  10. At present only few biological data are available to indicate whether psoriatic arthritis (PsA) is part of the spondyloarthropathy (SpA) concept, whether it is a separate disease entity or a heterogeneous dise...

    Authors: Elli Kruithof, Dominique Baeten, Leen De Rycke, Bernard Vandooren, Dirk Foell, Johannes Roth, Juan D Cañete, Annemieke M Boots, Eric M Veys and Filip De Keyser
    Citation: Arthritis Research & Therapy 2005 7:R569
  11. Autologous chondrocyte transplantation (ACT) has been shown, in long-term follow-up studies, to be a promising treatment for the repair of isolated cartilage lesions. The method is based on an implantation of in ...

    Authors: Tommi Tallheden, Catherine Bengtsson, Camilla Brantsing, Eva Sjögren-Jansson, Lars Carlsson, Lars Peterson, Mats Brittberg and Anders Lindahl
    Citation: Arthritis Research & Therapy 2005 7:R560
  12. Articular cartilage (hyaline cartilage) defects resulting from traumatic injury or degenerative joint disease do not repair themselves spontaneously. Therefore, such defects may require novel regenerative stra...

    Authors: Koji Hattori, Yoshinori Takakura, Hajime Ohgushi, Takashi Habata, Kota Uematsu, Jun Yamauchi, Kenji Yamashita, Takashi Fukuchi, Masao Sato and Ken Ikeuchi
    Citation: Arthritis Research & Therapy 2005 7:R552
  13. The development of drug-induced lupus remains a matter of concern in patients treated with anti-tumour necrosis factor (TNF) alpha. The incidence of such adverse effects is unknown. We undertook a retrospectiv...

    Authors: Michel De Bandt, Jean Sibilia, Xavier Le Loët, Sebastian Prouzeau, Bruno Fautrel, Christian Marcelli, Eric Boucquillard, Jean Louis Siame and Xavier Mariette
    Citation: Arthritis Research & Therapy 2005 7:R545

    The Editorial to this article has been published in Arthritis Research & Therapy 2019 21:235

  14. Synovial fluid from patients with various arthritides contains procoagulant, cell-derived microparticles. Here we studied whether synovial microparticles modulate the release of chemokines and cytokines by fib...

    Authors: René J Berckmans, Rienk Nieuwland, Maarten C Kraan, Marianne CL Schaap, Desirée Pots, Tom JM Smeets, Augueste Sturk and Paul P Tak
    Citation: Arthritis Research & Therapy 2005 7:R536
  15. The ank (progressive ankylosis) mutant mouse, which has a nonsense mutation in exon 12 of the inorganic pyrophosphate regulator gene (ank), exhibits aberrant joint ankylosis similar to human ankylosing spondyliti...

    Authors: Hing Wo Tsui, Robert D Inman, Andrew D Paterson, John D Reveille and Florence WL Tsui
    Citation: Arthritis Research & Therapy 2005 7:R513
  16. Cartilage destruction in the arthritides is thought to be mediated by two main enzyme families: the matrix metalloproteinases (MMPs) are responsible for cartilage collagen breakdown, and enzymes from the ADAMT...

    Authors: David A Young, Rachel L Lakey, Caroline J Pennington, Debra Jones, Lara Kevorkian, Dylan R Edwards, Timothy E Cawston and Ian M Clark
    Citation: Arthritis Research & Therapy 2005 7:R503
  17. Systemic lupus erythematosus and its murine equivalent, modelled in the New Zealand Black and New Zealand White (NZB × NZW)F1 hybrid strain, are polygenic inflammatory diseases, probably reflecting an autoimmune ...

    Authors: James I Elliott, John H McVey and Christopher F Higgins
    Citation: Arthritis Research & Therapy 2005 7:R468
  18. Autoantibodies directed against citrulline-containing proteins have an impressive specificity of nearly 100% in patients with rheumatoid arthritis and have been suggested to be involved in the disease pathogen...

    Authors: Karin Lundberg, Suzanne Nijenhuis, Erik R Vossenaar, Karin Palmblad, Walter J van Venrooij, Lars Klareskog, AJW Zendman and Helena Erlandsson Harris
    Citation: Arthritis Research & Therapy 2005 7:R458
  19. We analyzed the clinical response and the time to relapse after discontinuation of continuous long-term infliximab therapy in patients with ankylosing spondylitis (AS). After 3 years of infliximab therapy, all...

    Authors: Xenofon Baraliakos, Joachim Listing, Jan Brandt, Martin Rudwaleit, Joachim Sieper and Juergen Braun
    Citation: Arthritis Research & Therapy 2005 7:R439

    The Erratum to this article has been published in Arthritis Research & Therapy 2005 7:113

  20. Rheumatoid arthritis (RA) is a chronic inflammatory disease that produces synovial proliferation and joint erosions. The pathologic lesions of RA are driven through the production of inflammatory mediators in ...

    Authors: James C Keith Jr, Leo M Albert, Yelena Leathurby, Max Follettie, Lili Wang, Lisa Borges-Marcucci, Christopher C Chadwick, Robert J Steffan and Douglas C Harnish
    Citation: Arthritis Research & Therapy 2005 7:R427
  21. Natural killer T (NKT) cells have been implicated in the regulatory immune mechanisms that control autoimmunity. However, their precise role in the pathogenesis of rheumatoid arthritis (RA) remains unclear. Th...

    Authors: Loes Linsen, Marielle Thewissen, Kurt Baeten, Veerle Somers, Piet Geusens, Jef Raus and Piet Stinissen
    Citation: Arthritis Research & Therapy 2005 7:R493
  22. Rat models are frequently used for finding genes contributing to the arthritis phenotype. In most studies, however, limitations in the number of animals result in a low resolution. As a result, the linkage bet...

    Authors: Lars Andersson, Greta Petersen, Per Johnson and Fredrik Ståhl
    Citation: Arthritis Research & Therapy 2005 7:R485
  23. Rho is a major small GTP-binding protein that is involved in the regulation of various cell functions, including proliferation and cell migration, through activation of multiple signaling molecules in various ...

    Authors: Shingo Nakayamada, Hitoshi Kurose, Kazuyoshi Saito, Akira Mogami and Yoshiya Tanaka
    Citation: Arthritis Research & Therapy 2005 7:R476

Annual Journal Metrics

  • 2022 Citation Impact
    4.9 - 2-year Impact Factor
    5.7 - 5-year Impact Factor
    1.501 - SNIP (Source Normalized Impact per Paper)
    1.592 - SJR (SCImago Journal Rank)

    2023 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    111 days submission to accept (Median)

    2023 Usage 
    3,331,819 downloads
    1,885 Altmetric mentions